TrialBMC pharmacology & toxicology2022

Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants.

Takuma Yonemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.